254 related articles for article (PubMed ID: 34681921)
1. Multi-Omics Analysis of Gut Microbiota in Inflammatory Bowel Diseases: What Benefits for Diagnostic, Prognostic and Therapeutic Tools?
Lacroix V; Cassard A; Mas E; Barreau F
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681921
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?
Forbes JD; Chen CY; Knox NC; Marrie RA; El-Gabalawy H; de Kievit T; Alfa M; Bernstein CN; Van Domselaar G
Microbiome; 2018 Dec; 6(1):221. PubMed ID: 30545401
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease biomarkers of human gut microbiota selected via different feature selection methods.
Bakir-Gungor B; Hacılar H; Jabeer A; Nalbantoglu OU; Aran O; Yousef M
PeerJ; 2022; 10():e13205. PubMed ID: 35497193
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders.
Lopetuso LR; Petito V; Graziani C; Schiavoni E; Paroni Sterbini F; Poscia A; Gaetani E; Franceschi F; Cammarota G; Sanguinetti M; Masucci L; Scaldaferri F; Gasbarrini A
Dig Dis; 2018; 36(1):56-65. PubMed ID: 28683448
[TBL] [Abstract][Full Text] [Related]
5. Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD.
Poletti M; Arnauts K; Ferrante M; Korcsmaros T
J Crohns Colitis; 2021 Jul; 15(7):1222-1235. PubMed ID: 33341879
[TBL] [Abstract][Full Text] [Related]
6. The microbiome in inflammatory bowel disease: current status and the future ahead.
Kostic AD; Xavier RJ; Gevers D
Gastroenterology; 2014 May; 146(6):1489-99. PubMed ID: 24560869
[TBL] [Abstract][Full Text] [Related]
7. Gut mycobiome: The probable determinative role of fungi in IBD patients.
Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
9. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
Pisani A; Rausch P; Bang C; Ellul S; Tabone T; Marantidis Cordina C; Zahra G; Franke A; Ellul P
Microbiol Spectr; 2022 Jun; 10(3):e0061622. PubMed ID: 35532243
[TBL] [Abstract][Full Text] [Related]
10. An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?
Burman S; Hoedt EC; Pottenger S; Mohd-Najman NS; Ó Cuív P; Morrison M
Dig Dis; 2016; 34(1-2):64-71. PubMed ID: 26982568
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota, inflammatory bowel disease and colorectal cancer.
Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
13. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
[TBL] [Abstract][Full Text] [Related]
14. Dynamic Colonization of Microbes and Their Functions after Fecal Microbiota Transplantation for Inflammatory Bowel Disease.
Chu ND; Crothers JW; Nguyen LTT; Kearney SM; Smith MB; Kassam Z; Collins C; Xavier R; Moses PL; Alm EJ
mBio; 2021 Aug; 12(4):e0097521. PubMed ID: 34281401
[TBL] [Abstract][Full Text] [Related]
15. The oral-gut axis: Salivary and fecal microbiome dysbiosis in patients with inflammatory bowel disease.
Abdelbary MMH; Hatting M; Bott A; Dahlhausen A; Keller D; Trautwein C; Conrads G
Front Cell Infect Microbiol; 2022; 12():1010853. PubMed ID: 36275026
[TBL] [Abstract][Full Text] [Related]
16. The gut virome in inflammatory bowel disease pathogenesis: From metagenomics to novel therapeutic approaches.
Ungaro F; Massimino L; D'Alessio S; Danese S
United European Gastroenterol J; 2019 Oct; 7(8):999-1007. PubMed ID: 31662858
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
[TBL] [Abstract][Full Text] [Related]
18. The Role of Gut Microbiota in Inflammatory Bowel Disease-Current State of the Art.
Askari H; Shojaei-Zarghani S; Raeis-Abdollahi E; Jahromi HK; Abdullahi PR; Daliri K; Tajbakhsh A; Rahmati L; Safarpour AR
Mini Rev Med Chem; 2023; 23(13):1376-1389. PubMed ID: 36111766
[TBL] [Abstract][Full Text] [Related]
19. Poly-omic risk scores predict inflammatory bowel disease diagnosis.
Arehart CH; Sterrett JD; Garris RL; Quispe-Pilco RE; Gignoux CR; Evans LM; Stanislawski MA
mSystems; 2024 Jan; 9(1):e0067723. PubMed ID: 38095449
[TBL] [Abstract][Full Text] [Related]
20. Can control of gut microbiota be a future therapeutic option for inflammatory bowel disease?
Nishida A; Nishino K; Sakai K; Owaki Y; Noda Y; Imaeda H
World J Gastroenterol; 2021 Jun; 27(23):3317-3326. PubMed ID: 34163114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
